List view / Grid view

Inflammatory bowel disease (IBD)



Advancing novel biotherapeutics based on synthetic biology

22 September 2022 | By

Researchers at Synlogic are clearing the path for a new class of medicine – biotherapeutics based on synthetic biology, called synthetic biotics, which are created by programming or engineering bacteria to metabolise or secrete well-validated targets of disease pathophysiology. In this article, Dr Caroline Kurtz, Chief Development Officer at Synlogic, discusses how synthetic…